These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6779820)

  • 1. Membrane protein mediation of thromboxane A2-induced platelet aggregation.
    Kao KJ; Hagen PO; Pizzo SV
    Biochem Biophys Res Commun; 1980 Nov; 97(1):87-93. PubMed ID: 6779820
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of human platelet function by prostacyclin and thromboxane A2.
    Gorman RR
    Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereocontrolled synthesis of 7-oxabicyclo (2.2.1) heptane prostaglandin analogs as thromboxane A2 antagonists.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Res; 1980; 6():493-6. PubMed ID: 7189952
    [No Abstract]   [Full Text] [Related]  

  • 5. Impaired platelet response to thromboxane-A2 and defective calcium mobilization in a patient with a bleeding disorder.
    Lages B; Malmsten C; Weiss HJ; Samuelsson B
    Blood; 1981 Mar; 57(3):545-52. PubMed ID: 7459434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of etamsylate on platelet functions and arachidonic acid metabolism.
    Okuma M; Takayama H; Sugiyama T; Sensaki S; Uchino H
    Thromb Haemost; 1982 Dec; 48(3):330-3. PubMed ID: 6819650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pinane thromboxane A2: a TXA2 antagonist with antithrombotic properties.
    Aharony D; Smith JB; Smith EF; Lefer AM; Magolda RL; Nicolaou KD
    Adv Prostaglandin Thromboxane Res; 1980; 6():489-92. PubMed ID: 6992538
    [No Abstract]   [Full Text] [Related]  

  • 9. Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.
    Pollock WK; Armstrong RA; Brydon LJ; Jones RL; MacIntyre DE
    Biochem J; 1984 May; 219(3):833-42. PubMed ID: 6234886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal platelet response to thromboxane A2.
    Wu KK; Le Breton GC; Tai HH; Chen YC
    J Clin Invest; 1981 Jun; 67(6):1801-4. PubMed ID: 6263954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subnormal platelet response to thromboxane A2 in a patient with chronic myeloid leukaemia.
    Okuma M; Takayama H; Uchino H
    Br J Haematol; 1982 Jul; 51(3):469-77. PubMed ID: 6809032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonic acid-induced platelet aggregation and thromboxane A2 generation in patients with coronary heart disease.
    Szczeklik A; Gryglewski RJ; Musiał J; Grodzínska L; Serwónska M; Wójcik-Switek L; Marcinkiewicz E
    Acta Biol Med Ger; 1978; 37(5-6):741-2. PubMed ID: 742286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I; Block HU; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the vascular responses to various prostanoic compounds in the puppy and adult dog.
    Fitzpatrick T; Harris R; Ramwell P; Kot P
    Adv Prostaglandin Thromboxane Res; 1980; 7():727-9. PubMed ID: 6989200
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of strontium chloride on blood platelet function.
    Togna G; Gallozzi S; Caprino L
    Arch Toxicol Suppl; 1989; 13():366-9. PubMed ID: 2505737
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostacyclin (PGI2) and thromboxane A2 interaction in vivo. Regulation by aspirin and relationship with anti-thrombotic therapy.
    Korbut R; Moncada S
    Thromb Res; 1978 Sep; 13(3):489-500. PubMed ID: 369028
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombin, collagen and A23187 stimulated endogenous platelet arachidonate metabolism: differential inhibition by PGE1, local anesthetics and a serine-protease inhibitor.
    Feinstein MB; Becker EL; Fraser C
    Prostaglandins; 1977; 14(6):1075-93. PubMed ID: 341226
    [No Abstract]   [Full Text] [Related]  

  • 18. Defective platelet aggregation to the calcium ionophore A23187 in a patient with a lifelong bleeding disorder.
    Machin SJ; Keenan JP; McVerry BA
    J Clin Pathol; 1983 Oct; 36(10):1140-4. PubMed ID: 6413552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dominant role of thromboxane formation in secondary aggregation of platelets.
    Meyers KM; Seachord CL; Holmsen H; Smith JB; Prieur DJ
    Nature; 1979 Nov; 282(5736):331-3. PubMed ID: 503210
    [No Abstract]   [Full Text] [Related]  

  • 20. Independence of the cyclic AMP-lowering activity of thromboxane A2 from the platelet release reaction.
    Gorman RR; Wierenga W; Miller OV
    Biochim Biophys Acta; 1979 Jan; 572(1):95-104. PubMed ID: 216409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.